Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century.

The National Academy of Sciences publication, Toxicity Testing in the 21st Century: A Vision and a Strategy, proposes a paradigm shift in toxicology from current animal-based testing towards the application of emerging technologies, i.e., assays based on human cells or non-mammalian models, high throughput testing, omics approaches, systems biology, and computational modeling. These technologies should be used to identify how chemicals interact with cellular response networks and alter them to toxicity pathways. According to the authors, such a new paradigm would provide a better scientific understanding and more adequate data to predict the adverse effects of chemicals on human health. As expected from a vision document, the report enthusiastically and optimistically describes a radical transformation of toxicology from current practices to a new approach. Several toxicologists have commented on the report, and although they generally confirm the importance of the vision, they pose critical questions regarding its feasibility. Unlike the theoretical concepts, which are carefully described, many practical aspects of how to establish the vision are less well defined. Today's technologies provide great opportunities, although many challenges remain regarding their development, implementation, and validation to adequately assess human health effects. To bring the envisioned toxicology closer to concrete implementation, it is important to identify the current knowledge gaps in the vision and develop solutions. The goal of this review is to evaluate the technologies proposed as to their maturation to transform toxicity testing in the 21st century. This paper will provide an overview of the current standing by defining advantages, limitations, and developmental needs. In doing so, I do not intend to point out obstacles but, rather, to focus on current opportunities to advance toxicity testing for human risk assessment.

[1]  J. Southee,et al.  New epidermal model for dermal irritancy testing. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[2]  R. Weissleder,et al.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.

[3]  R. Phalen Commentary on ‘‘Toxicity Testing in the 21st Century: A vision and a Strategy’’ , 2010, Human & experimental toxicology.

[4]  E. Tiffany-Castiglioni,et al.  Evaluation of neurotoxic potential by use of in vitro systems , 2005, Expert opinion on drug metabolism & toxicology.

[5]  M. Čuperlović-Culf,et al.  Cell culture metabolomics: applications and future directions. , 2010, Drug discovery today.

[6]  K. Woltjen,et al.  New strategies to generate induced pluripotent stem cells. , 2009, Current opinion in biotechnology.

[7]  P. Vliet,et al.  Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology , 2009, Nature Protocols.

[8]  G Zbinden In vitro methods, past successes and future challenges. , 1990, Acta physiologica Scandinavica. Supplementum.

[9]  Melvin E Andersen,et al.  Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[10]  M. Vidyavathi,et al.  Role of Human Liver Microsomes in In Vitro Metabolism of Drugs—A Review , 2010, Applied biochemistry and biotechnology.

[11]  Thomas Hartung,et al.  Are in vitro tests suitable for regulatory use? , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  M. Usami,et al.  Proteomic analysis of selenium embryotoxicity in cultured postimplantation rat embryos. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.

[13]  Y. Wong,et al.  Reporter gene assays. , 2009, Methods in molecular biology.

[14]  D. Basketter,et al.  Proteomic analysis of the response of EpiDerm cultures to sodium lauryl sulphate. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  Dayong Wang,et al.  Adverse effects of metal exposure on chemotaxis towards water-soluble attractants regulated mainly by ASE sensory neuron in nematode Caenorhabditis elegans. , 2009, Journal of environmental sciences.

[16]  John D. Walker,et al.  An overview of the use of quantitative structure‐activity relationships for ranking and prioritizing large chemical inventories for environmental risk assessments , 2003, Environmental toxicology and chemistry.

[17]  Wolfgang Link,et al.  High content screening: seeing is believing. , 2010, Trends in biotechnology.

[18]  J. Pennings,et al.  Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity. , 2010, Reproductive toxicology.

[19]  M. Aschner,et al.  The use of astrocytes in culture as model systems for evaluating neurotoxic-induced-injury. , 1991, Neurotoxicology.

[20]  Mitchell D. Probasco,et al.  Feeder-independent culture of human embryonic stem cells , 2006, Nature Methods.

[21]  T. Riss,et al.  Bioluminescent assays for ADMET , 2008, Expert opinion on drug metabolism & toxicology.

[22]  Glen A. Evans,et al.  Designer science and the “omic” revolution , 2000, Nature Biotechnology.

[23]  K P Mishra,et al.  A review of high throughput technology for the screening of natural products. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  Neta Lavon Generation of hepatocytes from human embryonic stem cells. , 2010, Methods in molecular biology.

[25]  Sebastian Hoffmann,et al.  Diagnosis: toxic!--trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  Elaine Holmes,et al.  The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. , 2005, Pharmacogenomics.

[27]  T. Hartung Toxicology for the twenty-first century , 2009, Nature.

[28]  M. Chalfie,et al.  Green fluorescent protein as a marker for gene expression. , 1994, Science.

[29]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[30]  Yogeshwer Shukla,et al.  Toxicoproteomics: New paradigms in toxicology research , 2010, Toxicology mechanisms and methods.

[31]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[32]  F. Gage,et al.  Identification of small molecules from human embryonic stem cells using metabolomics. , 2007, Stem cells and development.

[33]  Robert Opoka,et al.  Investigating arsenic susceptibility from a genetic perspective in Drosophila reveals a key role for glutathione synthetase. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  Barbara A. Wetmore,et al.  Toxicoproteomics: proteomics applied to toxicology and pathology. , 2004, Toxicologic pathology.

[35]  Todd A. Clason,et al.  Methylmercury disruption of embryonic neural development in Drosophila. , 2009, Neurotoxicology.

[36]  Gordon Vansant,et al.  Gene expression profiling of rat livers reveals indicators of potential adverse effects. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  A. Guillouzo,et al.  Liver cell models in in vitro toxicology. , 1998, Environmental health perspectives.

[38]  L. Costa,et al.  Bridging the gap between in vitro and in vivo models for neurotoxicology. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  M. Kronick,et al.  Creation of the whole human genome microarray , 2004, Expert review of proteomics.

[40]  Andrew Worth,et al.  Overcoming Barriers to Validation of Non-animal Partial Replacement Methods/Integrated Testing Strategies: The Report of an EPAA–ECVAM Workshop , 2009, Alternatives to laboratory animals : ATLA.

[41]  B. Lu Recent advances in using Drosophila to model neurodegenerative diseases , 2009, Apoptosis.

[42]  B. Hammock,et al.  Mass spectrometry-based metabolomics. , 2007, Mass spectrometry reviews.

[43]  L. A. Glover,et al.  Rapid sublethal toxicity assessment using bioluminescent Caenorhabditis elegans, a novel whole-animal metabolic biosensor. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  M. Waters,et al.  Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods. , 2010, Mutation research.

[45]  Pratima Kundu,et al.  Generation of Hepatocyte-Like Cells from Human Embryonic Stem Cells , 2003, Cell transplantation.

[46]  Markus Reischl,et al.  Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. , 2009, Reproductive toxicology.

[47]  C. Jung,et al.  The Red Book , 2009 .

[48]  Scott A Noggle,et al.  Differentiation of Human Embryonic Stem Cells to Dopaminergic Neurons in Serum‐Free Suspension Culture , 2004, Stem cells.

[49]  Daniel Raftery,et al.  Quantitative Metabolomics by 1H-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes , 2010, PloS one.

[50]  Teck Chuan Lim,et al.  A microfluidic 3D hepatocyte chip for drug toxicity testing. , 2009, Lab on a chip.

[51]  B. Schwetz,et al.  Species sensitivities and prediction of teratogenic potential. , 1985, Environmental health perspectives.

[52]  Gert Lubec,et al.  Limitations of current proteomics technologies. , 2005, Journal of chromatography. A.

[53]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[54]  A. Knight Animal experiments scrutinised: systematic reviews demonstrate poor human clinical and toxicological utility. , 2007, ALTEX.

[55]  P. Wertz,et al.  The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[56]  W. Waddell Commentary on ‘‘Toxicity Testing in the 21st Century: A vision and a Strategy’’ , 2010, Human & experimental toxicology.

[57]  T. Hartung,et al.  A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. , 2008, Neurotoxicology.

[58]  Melvin E Andersen,et al.  Toxicity testing in the 21st century: bringing the vision to life. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[59]  Susanne Bremer,et al.  Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[60]  M. Aschner,et al.  Characterization of the effects of methylmercury on Caenorhabditis elegans. , 2009, Toxicology and applied pharmacology.

[61]  S. Kennedy The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[62]  A. Dicker,et al.  Zebrafish: An Emerging Model System for Human Disease and Drug Discovery , 2007, Clinical pharmacology and therapeutics.

[63]  T. Ideker,et al.  A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.

[64]  David M. Reif,et al.  In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project , 2009, Environmental health perspectives.

[65]  M. Sokolowski,et al.  Drosophila: Genetics meets behaviour , 2001, Nature Reviews Genetics.

[66]  D. L. Taylor,et al.  Systems cell biology based on high-content screening. , 2006, Methods in enzymology.

[67]  Donald G Robertson,et al.  Metabonomics in toxicology: a review. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[68]  P. Alves,et al.  Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors. , 2010, Tissue engineering. Part C, Methods.

[69]  Windy A. Boyd,et al.  Use of non-mammalian alternative models for neurotoxicological study. , 2008, Neurotoxicology.

[70]  M. Mann,et al.  4. Proteomic Analysis of Posttranslational Modifications , 2013 .

[71]  Hiroshi Yamada,et al.  Investigation of a hepatotoxicity screening system in primary cell cultures --"what biomarkers would need to be addressed to estimate toxicity in conventional and new approaches?". , 2005, The Journal of toxicological sciences.

[72]  M. Namba,et al.  Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[73]  F. Campos,et al.  Methylmercury disrupts the balance between phosphorylated and non-phosphorylated cofilin in primary cultures of mice cerebellar granule cells. A proteomic study. , 2010, Toxicology and applied pharmacology.

[74]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[75]  John Milner,et al.  Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. , 2006, Journal of the American Dietetic Association.

[76]  Jun Li,et al.  3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes. , 2010, Stem cells and development.

[77]  Michael D. Waters,et al.  Toxicogenomics and systems toxicology: aims and prospects , 2004, Nature Reviews Genetics.

[78]  E. Mardis Next-generation DNA sequencing methods. , 2008, Annual review of genomics and human genetics.

[79]  J. Pennings,et al.  Monitoring developmental toxicity in the embryonic stem cell test using differential gene expression of differentiation-related genes. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[80]  Gary D. Luker,et al.  Noninvasive Bioluminescence Imaging of Herpes Simplex Virus Type 1 Infection and Therapy in Living Mice , 2002, Journal of Virology.

[81]  M. Zurich,et al.  Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon , 1996, Brain Research.

[82]  N. Roy,et al.  Neurotoxicity assessment using zebrafish. , 2007, Journal of pharmacological and toxicological methods.

[83]  Thomas Dino Rockel,et al.  Human Neurospheres as Three-Dimensional Cellular Systems for Developmental Neurotoxicity Testing , 2009, Environmental health perspectives.

[84]  C Helma,et al.  Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments. , 2001, Environmental health perspectives.

[85]  Steven O Simmons,et al.  Gene expression changes in developing zebrafish as potential markers for rapid developmental neurotoxicity screening. , 2010, Neurotoxicology and teratology.

[86]  R. McKay,et al.  Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease , 2002, Nature.

[87]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.

[88]  J. Thomson,et al.  Hematopoietic and Endothelial Differentiation of Human Induced Pluripotent Stem Cells , 2009, Stem cells.

[89]  W. Purcell,et al.  Cryopreservation of Organotypic Brain Spheroid Cultures , 2003, Alternatives to laboratory animals : ATLA.

[90]  Christopher J Cronin,et al.  Automated imaging of C. elegans behavior. , 2006, Methods in molecular biology.

[91]  L. Costa,et al.  Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos. , 2004, Toxicology and applied pharmacology.

[92]  Fumiaki Katagiri,et al.  Overview of mRNA Expression Profiling Using DNA Microarrays , 2009, Current protocols in molecular biology.

[93]  Marc Bickle,et al.  Image Analysis in High Content Screening , 2009 .

[94]  H. Baharvand,et al.  Enhanced Functions of Human Embryonic Stem Cell-derived Hepatocyte-like Cells on Three-dimensional Nanofibrillar Surfaces , 2010, Stem Cell Reviews and Reports.

[95]  A. Rubinstein,et al.  The use of in vivo zebrafish assays in drug toxicity screening , 2009 .

[96]  L. Cubeddu QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. , 2003, American journal of therapeutics.

[97]  Mckusick Va Genomics: structural and functional studies of genomes. , 1997 .

[98]  A. Ting,et al.  Fluorescent probes for super-resolution imaging in living cells , 2008, Nature Reviews Molecular Cell Biology.

[99]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[100]  S. Nishikawa,et al.  Chamber‐specific differentiation of Nkx2.5‐positive cardiac precursor cells from murine embryonic stem cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[101]  A. Piersma,et al.  Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. , 2000, In vitro & molecular toxicology.

[102]  Robbert Creton,et al.  Automated analysis of behavior in zebrafish larvae , 2009, Behavioural Brain Research.

[103]  Robert E Chapin,et al.  Endless possibilities: stem cells and the vision for toxicology testing in the 21st century. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[104]  D. Rancourt,et al.  Identification of Five Developmental Processes during Chondrogenic Differentiation of Embryonic Stem Cells , 2010, PloS one.

[105]  J. Lindon,et al.  Systems biology: Metabonomics , 2008, Nature.

[106]  Nancy M Bonini,et al.  Drosophila as a model for human neurodegenerative disease. , 2005, Annual review of genetics.

[107]  C Winder,et al.  Toxicity Assessment of Industrial Chemicals and Airborne Contaminants: Transition from In Vivo to In Vitro Test Methods: A Review , 2005, Inhalation toxicology.

[108]  Ben van Ommen,et al.  Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology , 2005, Expert review of proteomics.

[109]  Bifeng Liu,et al.  Optical molecular imaging for systems biology: from molecule to organism , 2006, Analytical and bioanalytical chemistry.

[110]  Kai Licha,et al.  Near-infrared fluorescent probes for imaging vascular pathophysiology , 2008, Basic Research in Cardiology.

[111]  P. Carmichael,et al.  Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. , 2007, Mutation research.

[112]  D. Menick,et al.  Generation of novel reporter stem cells and their application for molecular imaging of cardiac-differentiated stem cells in vivo. , 2010, Stem cells and development.

[113]  Daniel Cerutti,et al.  Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. , 2010, Neurotoxicology and teratology.

[114]  N. Kotov,et al.  Three-dimensional cell culture matrices: state of the art. , 2008, Tissue engineering. Part B, Reviews.

[115]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[116]  B. Daraei,et al.  Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity , 2010, Xenobiotica; the fate of foreign compounds in biological systems.

[117]  Manfred Liebsch,et al.  Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data , 2010, Contact dermatitis.

[118]  Karim Oudina,et al.  In vitro and in vivo bioluminescent quantification of viable stem cells in engineered constructs. , 2010, Tissue engineering. Part C, Methods.

[119]  G. Leuba,et al.  Involvement of microglia–neuron interactions in the tumor necrosis factor‐α release, microglial activation, and neurodegeneration induced by trimethyltin , 2003, Journal of neuroscience research.

[120]  M. Stevens Toxicology: Testing in the third dimension. , 2009, Nature nanotechnology.

[121]  Thomas Hartung,et al.  Food for thought... on animal tests. , 2008, ALTEX.

[122]  J. Truman,et al.  Metamorphosis of the central nervous system of Drosophila. , 1990, Journal of neurobiology.

[123]  R. Tyl,et al.  Metabolomics in the assessment of chemical‐induced reproductive and developmental outcomes using non‐invasive biological fluids: application to the study of butylbenzyl phthalate , 2009, Journal of applied toxicology : JAT.

[124]  Xiaozhong Peng,et al.  Proteomic analysis of cardiomyocytes differentiation in mouse embryonic carcinoma P19CL6 cells , 2007, Journal of cellular biochemistry.

[125]  N. Steimberg,et al.  Modelling tissues in 3D: the next future of pharmaco-toxicology and food research? , 2009, Genes & Nutrition.

[126]  Annie L. Conery,et al.  Whole-animal high-throughput screens: the C. elegans model. , 2009, Methods in molecular biology.

[127]  Shichang Zhang,et al.  Hepatic differentiation of mouse embryonic stem cells in three-dimensional polymer scaffolds. , 2010, Tissue engineering. Part A.

[128]  J. Thivolet,et al.  In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. , 1991, Experimental cell research.

[129]  P. Predki,et al.  Functional protein microarrays: just how functional are they? , 2005, Current opinion in biotechnology.

[130]  S. O. Mueller,et al.  Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: a valuable model for in vitro toxicity and drug-drug interaction studies. , 2009, Chemico-biological interactions.

[131]  M. Balls,et al.  Mechanistic approaches and the development of alternative toxicity test methods. , 1998, Environmental health perspectives.

[132]  Tiago G Fernandes,et al.  High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. , 2009, Trends in biotechnology.

[133]  A. Aderem Systems Biology: Its Practice and Challenges , 2005, Cell.

[134]  Makoto Ojika,et al.  Firefly luciferase is a bifunctional enzyme: ATP‐dependent monooxygenase and a long chain fatty acyl‐CoA synthetase , 2003, FEBS letters.

[135]  H. Kitano Systems Biology: A Brief Overview , 2002, Science.

[136]  J. Zock,et al.  Applications of High Content Screening in Life Science Research , 2009, Combinatorial chemistry & high throughput screening.

[137]  P. Honegger Aggregating neural cell cultures. , 2003, Current protocols in toxicology.

[138]  D. Dix,et al.  The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[139]  David C Hay,et al.  Efficient Differentiation of Hepatocytes from Human Embryonic Stem Cells Exhibiting Markers Recapitulating Liver Development In Vivo , 2008, Stem cells.

[140]  Takeshi Suzuki,et al.  Recent Advances in Fluorescent Labeling Techniques for Fluorescence Microscopy , 2007, Acta histochemica et cytochemica.

[141]  G Gstraunthaler,et al.  Nephrotoxicity testing in vitro--what we know and what we need to know. , 1998, Environmental health perspectives.

[142]  T. Hartung,et al.  mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[143]  Sebastian Hoffmann,et al.  Food for thought ... on in silico methods in toxicology. , 2009, ALTEX.

[144]  Ruedi Aebersold,et al.  7th HUPO World Congress of Proteomics: Launching the Second Phase of the HUPO Plasma Proteome Project (PPP‐2) 16–20 August 2008, Amsterdam, The Netherlands , 2009, Proteomics.

[145]  D. Stolz,et al.  Long term cultures of primary human hepatocytes as an alternative to drug testing in animals. , 2009, ALTEX.

[146]  Kwang-Soo Kim,et al.  Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons , 2002, The European journal of neuroscience.

[147]  M. Rand,et al.  Drosophotoxicology: the growing potential for Drosophila in neurotoxicology. , 2010, Neurotoxicology and teratology.

[148]  D. Hay,et al.  Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening. , 2010, Toxicology.

[149]  Phillip L. Williams,et al.  Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[150]  A. Ferrer-Dufol,et al.  Toxicogenomics and clinical toxicology: an example of the connection between basic and applied sciences. , 2009, Toxicology letters.

[151]  René Thierbach,et al.  A high-throughput reporter gene assay to prove the ability of natural compounds to modulate glutathione peroxidase, superoxide dismutase and catalase gene promoters in V79 cells , 2008, Free radical research.

[152]  P. Mali,et al.  Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions , 2010, Stem cells.

[153]  H. Yoon,et al.  Hepatic differentiation of cord blood‐derived multipotent progenitor cells (MPCs) in vitro , 2008, Cell biology international.

[154]  A. Franchitto,et al.  New insights into liver stem cells. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[155]  C. Nichols,et al.  Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery. , 2006, Pharmacology & therapeutics.

[156]  J. Itskovitz‐Eldor,et al.  Development of cardiomyocytes from human ES cells. , 2003, Methods in enzymology.

[157]  S. Dima,et al.  In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors. , 2009, Translational research : the journal of laboratory and clinical medicine.

[158]  John Doull,et al.  Pragmatic Challenges for the Vision of Toxicity Testing in the 21st Century in a Regulatory Context: Another Ames Test? …or a New Edition of “the Red Book”? , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[159]  Thomas Hartung,et al.  Food for thought ... on alternative methods for cosmetics safety testing. , 2008, ALTEX.

[160]  Phillip L. Williams,et al.  The nematode Caenorhabditis elegans as a model of organophosphate-induced mammalian neurotoxicity. , 2004, Toxicology and applied pharmacology.

[161]  King Li,et al.  Systems diagnostics: the systems approach to molecular imaging. , 2009, AJR. American journal of roentgenology.

[162]  Charles W. Schmidt,et al.  TOX 21: New Dimensions of Toxicity Testing , 2009, Environmental health perspectives.

[163]  Tanja Waldmann,et al.  Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. , 2010, ALTEX.

[164]  James L Stevens,et al.  Future of toxicology--mechanisms of toxicity and drug safety: where do we go from here? , 2006, Chemical research in toxicology.

[165]  C. Funck-Brentano,et al.  Droperidol and Ondansetron-induced QT Interval Prolongation: A Clinical Drug Interaction Study , 2008, Anesthesiology.

[166]  Larry Bull,et al.  Electrophysiological measurements in three-dimensional in vivo-mimetic organotypic cell cultures: Preliminary studies with hen embryo brain spheroids , 2006, Neuroscience Letters.

[167]  Philip G Hewitt,et al.  Acute hepatotoxicity: a predictive model based on focused illumina microarrays. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[168]  N. Kobayashi,et al.  Long-Term Culture of Japanese Human Embryonic Stem Cells in Feeder-Free Conditions , 2008, Cell transplantation.

[169]  F. Mottaghy,et al.  Method of bioluminescence imaging for molecular imaging of physiological and pathological processes. , 2009, Methods.

[170]  Robert J Kavlock,et al.  Understanding mechanisms of toxicity: insights from drug discovery research. , 2008, Toxicology and applied pharmacology.

[171]  J. Pennings,et al.  Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells. , 2010, Toxicology and applied pharmacology.

[172]  A. Guillouzo,et al.  Stem cell-derived hepatocytes and their use in toxicology. , 2010, Toxicology.

[173]  T Hartung,et al.  Three Rs potential in the development and quality control of pharmaceuticals. , 2001, ALTEX.

[174]  Francesco Pampaloni,et al.  Three-dimensional tissue models for drug discovery and toxicology. , 2009, Recent patents on biotechnology.

[175]  P. Doevendans,et al.  The human adult cardiomyocyte phenotype. , 2003, Cardiovascular research.

[176]  E. Kunkel Systems biology in drug discovery , 2004, Nature Biotechnology.

[177]  J. Kleinjans,et al.  Assessing the Metabolic Competence of Sandwich-Cultured Mouse Primary Hepatocytes , 2009, Drug Metabolism and Disposition.

[178]  Jason R Swedlow,et al.  Live cell imaging using wide-field microscopy and deconvolution. , 2002, Cell structure and function.

[179]  C. Mummery,et al.  Proteomics and human embryonic stem cells. , 2008, Stem cell research.

[180]  M. Denison,et al.  Toxicology in the Fast Lane: Application of High-Throughput Bioassays to Detect Modulation of Key Enzymes and Receptors , 2009, Environmental health perspectives.

[181]  G. Luker,et al.  Bioluminescence imaging of reporter mice for studies of infection and inflammation. , 2010, Antiviral research.

[182]  L. Boscá,et al.  Cilastatin Attenuates Cisplatin-Induced Proximal Tubular Cell Damage , 2010, Journal of Pharmacology and Experimental Therapeutics.

[183]  Joseph C. Wu,et al.  In vitro and in vivo bioluminescence reporter gene imaging of human embryonic stem cells. , 2008, Journal of visualized experiments : JoVE.

[184]  D. Rank,et al.  Application of genomics to toxicology research. , 2002, Environmental health perspectives.

[185]  Hoguen Kim,et al.  Protein profiling of human plasma samples by two-dimensional electrophoresis. , 2008, Methods in molecular biology.

[186]  R. Pearce,et al.  Directed Differentiation of Dopaminergic Neuronal Subtypes from Human Embryonic Stem Cells , 2005, Stem cells.

[187]  Pengyuan Yang,et al.  Proteome alteration of early‐stage differentiation of mouse embryonic stem cells into hepatocyte‐like cells , 2009, Electrophoresis.

[188]  V. Thongboonkerd Urinary proteomics: towards biomarker discovery, diagnostics and prognostics. , 2008, Molecular bioSystems.

[189]  Richard A Becker,et al.  Toxicity testing in the 21st century: a view from the chemical industry. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[190]  Li-Rong Yu,et al.  Quantitative proteomics for drug toxicity. , 2009, Briefings in functional genomics & proteomics.

[191]  P. Honegger,et al.  Growth and differentiation of aggregating fetal brain cells in a serum-free defined medium , 1979, Nature.

[192]  H. Baharvand,et al.  Differentiation of human embryonic stem cells into functional hepatocyte-like cells in a serum-free adherent culture condition. , 2008, Differentiation; research in biological diversity.

[193]  M. Bittner,et al.  Expression profiling using cDNA microarrays , 1999, Nature Genetics.

[194]  Lorenz M Mayr,et al.  Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.

[195]  Jehyuk Lee,et al.  Generation of functional human hepatic endoderm from human induced pluripotent stem cells , 2009, Hepatology.

[196]  B. van Ravenzwaay,et al.  The use of metabolomics for the discovery of new biomarkers of effect. , 2007, Toxicology letters.

[197]  Lee Weng,et al.  Toxicogenomic analysis methods for predictive toxicology. , 2006, Journal of pharmacological and toxicological methods.

[198]  F. Collins,et al.  The Human Genome Project: Lessons from Large-Scale Biology , 2003, Science.

[199]  Andrew Worth,et al.  Metabolism: A Bottleneck in In Vitro Toxicological Test Development , 2006, Alternatives to laboratory animals : ATLA.

[200]  J. Frangioni In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[201]  S. Theocharis,et al.  Toxicogenomics: a pivotal piece in the puzzle of toxicological research , 2007, Journal of applied toxicology : JAT.

[202]  A. Birkeland,et al.  Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[203]  C. Bolognesi,et al.  Genetic Susceptibility to Benzene Toxicity in Humans , 2008, Journal of toxicology and environmental health. Part A.

[204]  P. Landrigan,et al.  Developmental neurotoxicity of industrial chemicals , 2006, The Lancet.

[205]  Anna Forsby,et al.  Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity , 2007, Human & experimental toxicology.

[206]  Elaine Holmes,et al.  Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. , 2007, Journal of proteome research.

[207]  T Seidle,et al.  Bringing toxicology into the 21st century: a global call to action. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[208]  G. Luker,et al.  Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation. , 2008, Antiviral research.

[209]  W. Schoonen,et al.  High-throughput screening for analysis of in vitro toxicity. , 2009, EXS.

[210]  Robert J Kavlock,et al.  Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[211]  Elisabeth Schmidt,et al.  Assessment of the Skin Irritation Potential of Chemicals by Using the SkinEthic Reconstructed Human Epidermal Model and the Common Skin Irritation Protocol Evaluated in the ECVAM Skin Irritation Validation Study , 2006, Alternatives to laboratory animals : ATLA.

[212]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[213]  Christian Giaume,et al.  Pathways of neuron-astrocyte interactions and their possible role in neuroprotection , 2001, European Archives of Psychiatry and Clinical Neuroscience.

[214]  C. Teunissen,et al.  An in vitro model for de‐ and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures , 2009, Glia.

[215]  Dhanashree S. Kelkar,et al.  Temporal analysis of neural differentiation using quantitative proteomics. , 2009, Journal of proteome research.

[216]  A. Carere,et al.  In vitro toxicology methods: impact on regulation from technical and scientific advancements. , 2002, Toxicology letters.

[217]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[218]  Edgar Ben-Josef,et al.  In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation. , 2010, Translational oncology.

[219]  Lior Gepstein,et al.  In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. , 2009, Stem cells and development.

[220]  P. Wedeking,et al.  CAENORHABDITIS ELEGANS AS AN ALTERNATIVE ANIMAL SPECIES , 2000, Journal of toxicology and environmental health. Part A.

[221]  U. Lendahl,et al.  Generalized potential of adult neural stem cells. , 2000, Science.

[222]  H. McLeod,et al.  Small inhibitory RNA--a tool for credentialing candidate genes. , 2005, Pharmacogenomics.

[223]  T. Schettler,et al.  Toxic threats to neurologic development of children. , 2001, Environmental health perspectives.

[224]  David S Wishart,et al.  Human Metabolome Database: completing the 'human parts list'. , 2007, Pharmacogenomics.

[225]  P. James,et al.  Protein identification in the post-genome era: the rapid rise of proteomics , 1997, Quarterly Reviews of Biophysics.

[226]  Karl-Heinz Krause,et al.  The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. , 2008, ALTEX.

[227]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[228]  Marilyn J. Aardema,et al.  Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. , 2002 .

[229]  Timothy J Carlson,et al.  Recent advances in high throughput screening for ADME properties. , 2008, Combinatorial chemistry & high throughput screening.

[230]  P. R. Contag,et al.  In vivo bioluminescent monitoring of chemical toxicity using heme oxygenase-luciferase transgenic mice. , 2004, Toxicology and applied pharmacology.

[231]  L. Liotta,et al.  Reverse-phase protein microarrays: application to biomarker discovery and translational medicine , 2007, Expert review of molecular diagnostics.

[232]  Commentary on ‘‘Toxicity Testing in the 21st Century: A vision and a Strategy’’ , 2010, Human & experimental toxicology.

[233]  P. West,et al.  Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. , 2010, Toxicology and applied pharmacology.

[234]  M. Morris,et al.  Fluorescent Biosensors of Intracellular Targets from Genetically Encoded Reporters to Modular Polypeptide Probes , 2009, Cell Biochemistry and Biophysics.

[235]  S. Fields,et al.  Protein analysis on a proteomic scale , 2003, Nature.

[236]  Robert Lanza,et al.  Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells , 2008, Stem cells.

[237]  Stefan Wagner,et al.  Generation of induced pluripotent stem cells from human cord blood. , 2009, Cell stem cell.

[238]  J. Bereiter-Hahn,et al.  Differentiation Status of Human Renal Proximal and Distal Tubular Epithelial Cells in vitro: Differential Expression of Characteristic Markers , 2006, Cells Tissues Organs.

[239]  John D. Walker,et al.  QSARs for identifying and prioritizing substances with persistence and bioconcentration potential , 2002, SAR and QSAR in environmental research.

[240]  Aldert Piersma,et al.  The Practical Application of Three Validated In Vitro Embryotoxicity Tests , 2006, Alternatives to laboratory animals : ATLA.

[241]  Thomas Hartung,et al.  Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)). , 2009, ALTEX.

[242]  Peter Sartipy,et al.  Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery. , 2009, Current opinion in drug discovery & development.

[243]  N. Kobayashi,et al.  Endoderm induction for hepatic and pancreatic differentiation of ES cells. , 2008, Acta medica Okayama.

[244]  David R. Kaplan,et al.  A dermal niche for multipotent adult skin-derived precursor cells , 2004, Nature Cell Biology.

[245]  R. Dhawan,et al.  Comparison of lethality, reproduction, and behavior as toxicological endpoints in the nematode Caenorhabditis elegans. , 1999, Journal of toxicology and environmental health. Part A.

[246]  James S MacDonald,et al.  Toxicity testing in the 21st century: a view from the pharmaceutical industry. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[247]  M. Pittenger,et al.  Mesenchymal stem cells from adult bone marrow. , 2008, Methods in molecular biology.

[248]  Thomas Hartung,et al.  A Toxicology for the 21st Century—Mapping the Road Ahead , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[249]  Kathryn E. Luker,et al.  Optical Imaging: Current Applications and Future Directions , 2007, Journal of Nuclear Medicine.

[250]  Martin L Yarmush,et al.  Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. , 2008, Tissue engineering. Part A.

[251]  A. Misra,et al.  SNP genotyping: technologies and biomedical applications. , 2007, Annual review of biomedical engineering.

[252]  M. Boguski,et al.  Functional genomics: it's all how you read it. , 1997, Science.

[253]  M. Aschner,et al.  Utility of Caenorhabditis elegans in high throughput neurotoxicological research. , 2010, Neurotoxicology and teratology.

[254]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[255]  H Tanaka,et al.  Omics-based Medicine and Systems Pathology , 2010, Methods of Information in Medicine.

[256]  N. Walker Real‐time and quantitative PCR: applications to mechanism‐based toxicology , 2001, Journal of biochemical and molecular toxicology.

[257]  Leonora Buzanska,et al.  A Human Stem Cell‐Based Model for Identifying Adverse Effects of Organic and Inorganic Chemicals on the Developing Nervous System , 2009, Stem cells.

[258]  A. Kinsner-Ovaskainen,et al.  Neuronal in vitro models for the estimation of acute systemic toxicity. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[259]  Phillip L Williams,et al.  Assessing behavioral toxicity with Caenorhabditis elegans , 2004, Environmental toxicology and chemistry.

[260]  Silke Gabbert,et al.  Towards optimization of chemical testing under REACH: a Bayesian network approach to Integrated Testing Strategies. , 2010, Regulatory toxicology and pharmacology : RTP.

[261]  Thomas Hartung,et al.  Workgroup Report: Incorporating In Vitro Alternative Methods for Developmental Neurotoxicity into International Hazard and Risk Assessment Strategies , 2007, Environmental health perspectives.

[262]  Shuk Han Cheng,et al.  Noninvasive technique for measurement of heartbeat regularity in zebrafish (Danio rerio) embryos , 2009, BMC biotechnology.

[263]  M. Mann,et al.  Proteomic analysis of post-translational modifications , 2003, Nature Biotechnology.

[264]  T. Kavanagh,et al.  Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE-71. , 2009, Neurotoxicology.

[265]  Anne E Carpenter,et al.  Systematic genome-wide screens of gene function , 2004, Nature Reviews Genetics.

[266]  S. Schuster Next-generation sequencing transforms today's biology , 2008, Nature Methods.

[267]  P. S. Rajini,et al.  Evaluation of sublethal effects of dichlorvos upon Caenorhabditis elegans based on a set of end points of toxicity , 2009, Journal of biochemical and molecular toxicology.

[268]  W. Kaiser,et al.  An in vitro characterization study of new near infrared dyes for molecular imaging. , 2009, European journal of medicinal chemistry.

[269]  Mitchell Klausner,et al.  Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay. , 2009, Mutation research.

[270]  T. Blackwell,et al.  Bioluminescence: imaging modality for in vitro and in vivo gene expression. , 2008, Methods in molecular biology.

[271]  Richard E Peterson,et al.  Zebrafish as a model vertebrate for investigating chemical toxicity. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[272]  Andrew C. Giles,et al.  Behavioral and genetic characterization of habituation using Caenorhabditis elegans , 2009, Neurobiology of Learning and Memory.

[273]  Timothy J Shafer,et al.  Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[274]  John D. Walker,et al.  Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. , 2003, Environmental health perspectives.

[275]  T. Tuschl,et al.  Analysis of gene function in somatic mammalian cells using small interfering RNAs. , 2002, Methods.

[276]  Nathalie Alépée,et al.  A catch-up validation study on reconstructed human epidermis (SkinEthic RHE) for full replacement of the Draize skin irritation test. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[277]  Ludovic Vallier,et al.  Signaling Pathways Controlling Pluripotency and Early Cell Fate Decisions of Human Induced Pluripotent Stem Cells , 2009, Stem cells.

[278]  M. Bate,et al.  Spatial and temporal patterns of neurogenesis in the central nervous system of Drosophila melanogaster. , 1988, Developmental biology.

[279]  H. Kamp,et al.  Influence of strain and sex on the metabolic profile of rats in repeated dose toxicological studies. , 2009, Toxicology letters.

[280]  M. Taussig,et al.  Protein microarrays: high-throughput tools for proteomics , 2009, Expert review of proteomics.

[281]  P. Kuwabara,et al.  Nucleotide excision repair and the degradation of RNA pol II by the Caenorhabditis elegans XPA and Rsp5 orthologues, RAD-3 and WWP-1. , 2008, DNA Repair.

[282]  J. Kleinjans,et al.  Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. , 2005, Mutation research.

[283]  J. Waring,et al.  Application of a High-Content Multiparameter Cytotoxicity Assay to Prioritize Compounds Based on Toxicity Potential in Humans , 2008, Journal of biomolecular screening.

[284]  Walker Inman,et al.  Liver tissue engineering in the evaluation of drug safety , 2009, Expert opinion on drug metabolism & toxicology.

[285]  S. Nishikawa,et al.  Embryonic stem-cell culture as a tool for developmental cell biology , 2007, Nature Reviews Molecular Cell Biology.

[286]  M. Zurich,et al.  Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures , 2007, Human & experimental toxicology.

[287]  Marilyn J Aardema,et al.  Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). , 2006, Mutation research.

[288]  T. Hartung,et al.  Gene expression as a sensitive endpoint to evaluate cell differentiation and maturation of the developing central nervous system in primary cultures of rat cerebellar granule cells (CGCs) exposed to pesticides. , 2009, Toxicology and applied pharmacology.

[289]  Alejandro Soto-Gutiérrez,et al.  Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. , 2009, Gastroenterology.

[290]  H. Tilson,et al.  In vitro techniques for the assessment of neurotoxicity. , 1998, Environmental health perspectives.

[291]  I. Hauser,et al.  Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[292]  Michael O. Hengartner,et al.  Finding function in novel targets: C. elegans as a model organism , 2006, Nature Reviews Drug Discovery.

[293]  H. Hirsch,et al.  Effects of chronic lead exposure on the neuromuscular junction in Drosophila larvae. , 2003, Neurotoxicology.

[294]  F. Collins,et al.  Transforming Environmental Health Protection , 2008, Science.

[295]  P. Bernardi,et al.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.

[296]  T. Walker,et al.  The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture , 1999, Cell Biology and Toxicology.

[297]  James A Thomson,et al.  Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency , 2010, Proceedings of the National Academy of Sciences.